XML 69 R99.htm IDEA: XBRL DOCUMENT v2.4.0.6
Segment Reporting - Schedule Of Revenues By Product Lines (Detail) (USD $)
In Thousands, unless otherwise specified
3 Months Ended 12 Months Ended
Dec. 31, 2012
Sep. 30, 2012
Jul. 01, 2012
Apr. 01, 2012
Dec. 31, 2011
Oct. 02, 2011
Jul. 03, 2011
Apr. 03, 2011
Dec. 31, 2012
Dec. 31, 2011
Dec. 31, 2010
Segment Reporting Information [Line Items]                      
Revenues $ 216,600 $ 192,800 [1] $ 201,000 [1] $ 179,700 [2] $ 236,800 [3] $ 211,800 $ 221,100 $ 178,500 $ 790,093 $ 848,181 $ 679,111
Systems And Solutions
                     
Segment Reporting Information [Line Items]                      
Revenues                 380,729 423,434 381,618
Printer And Media
                     
Segment Reporting Information [Line Items]                      
Revenues                 148,875 175,408 163,640
Intermec-Branded Services
                     
Segment Reporting Information [Line Items]                      
Revenues                 138,246 143,127 133,853
Voice Solutions
                     
Segment Reporting Information [Line Items]                      
Revenues                 $ 122,243 $ 106,212 $ 0
[1] Net (loss) earnings, basic (loss) earnings per share, and diluted (loss) earnings per share for the second and third quarters of 2012 have been corrected from amounts previously reported, as described in the section below titled "Immaterial Restatement of Goodwill Impairment."2011Q1 Q2 Q3 Q43Revenues$178.5 $221.1 $211.8 $236.8Gross profit68.3 91.3 87.8 99.3Net (loss) earnings(6.0) (3.8) 0.7 (21.6) Basic (loss) earnings per share$(0.10) $(0.06) $0.01 $(0.36)Diluted (loss) earnings per share$(0.10) $(0.06) $0.01 $(0.36)3 In the fourth quarter of 2011, we recorded an expense of $20.9 million for a valuation allowance against a portion of our U.S. deferred tax assets.
[2] In the first quarter of 2012, we recognized expense of $206.9 million for a valuation allowance against a portion of our U.S. deferred tax assets.
[3] In the fourth quarter of 2011, we recorded an expense of $20.9 million for a valuation allowance against a portion of our U.S. deferred tax assets.